New Key Statistics Module, Z-Score and F-Score
OTCPK:TEVVF.PFD Key Ratios
Market Cap $ M | -- |
Enterprise Value $ M | -- |
P/E(ttm) | -- |
PE Ratio without NRI | 6.27 |
Forward PE Ratio | 5.43 |
Price/Book | 2.57 |
Price/Sales | 1.16 |
Price/Free Cash Flow | 21.02 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | -2.38 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 191.07 |
EV-to-EBITDA | 27.19 |
PEG | -- |
Shares Outstanding M | -- |
Net Margin (%) | -3.08 |
Operating Margin % | 20.79 |
Pre-tax Margin (%) | -5.21 |
Quick Ratio | 0.61 |
Current Ratio | 0.89 |
ROA % (ttm) | -1.15 |
ROE % (ttm) | -6.73 |
ROIC % (ttm) | 8.37 |
Dividend Yield % | 4.93 |
Altman Z-Score | 0.22 |
TEVVF.PFD Number of Guru Trades
TEVVF.PFD Volume of Guru Trades
Gurus Latest Trades with OTCPK:TEVVF.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TEVVF.PFD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Teva Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about OTCPK:TEVVF.PFD
Total 0- 1